Byung-Ho Nam

Author PubWeight™ 130.31‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA 2004 4.63
2 C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study. Arch Intern Med 2005 3.31
3 Randomized clinical trial of weekly vs. triweekly cisplatin-based chemotherapy concurrent with radiotherapy in the treatment of locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2011 3.01
4 Association of family history with cancer recurrence and survival in patients with gastric cancer. J Clin Oncol 2012 2.97
5 Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma. J Hepatol 2012 2.94
6 Accuracy of offspring reports of parental cardiovascular disease history: the Framingham Offspring Study. Ann Intern Med 2004 2.74
7 Resumption of imatinib to control metastatic or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib (RIGHT): a randomised, placebo-controlled, phase 3 trial. Lancet Oncol 2013 2.42
8 A likely explanation for the J-curve of blood pressure cardiovascular risk. Am J Cardiol 2004 2.36
9 Real-time endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer: how many aspirations per target lymph node station? Chest 2008 2.31
10 Transbronchial and transesophageal fine-needle aspiration using an ultrasound bronchoscope in mediastinal staging of potentially operable lung cancer. Chest 2010 2.28
11 EBUS-centred versus EUS-centred mediastinal staging in lung cancer: a randomised controlled trial. Thorax 2013 2.21
12 Surgical complications and the risk factors of laparoscopy-assisted distal gastrectomy in early gastric cancer. Ann Surg Oncol 2008 2.10
13 Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults. JAMA 2005 2.05
14 Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2002 2.00
15 Abdominal visceral adipose tissue volume is associated with increased risk of erosive esophagitis in men and women. Gastroenterology 2010 2.00
16 Phase III, multicenter, randomized trial of maintenance chemotherapy versus observation in patients with metastatic breast cancer after achieving disease control with six cycles of gemcitabine plus paclitaxel as first-line chemotherapy: KCSG-BR07-02. J Clin Oncol 2013 1.96
17 Prognostic value of preoperative clinical staging assessed by computed tomography in resectable gastric cancer patients: a viewpoint in the era of preoperative treatment. Ann Surg 2010 1.84
18 Relations of insulin sensitivity to longitudinal blood pressure tracking: variations with baseline age, body mass index, and blood pressure. Circulation 2005 1.75
19 Association of parental heart failure with risk of heart failure in offspring. N Engl J Med 2006 1.69
20 C-reactive protein, inflammatory conditions, and cardiovascular disease risk. Am J Med 2007 1.64
21 Low initial human papilloma viral load implicates worse prognosis in patients with uterine cervical cancer treated with radiotherapy. J Clin Oncol 2009 1.56
22 Survival of patients with advanced hepatocellular carcinoma: sorafenib versus other treatments. J Gastroenterol Hepatol 2011 1.55
23 Developing an institutional protocol guideline for laparoscopy-assisted distal gastrectomy. Ann Surg Oncol 2009 1.51
24 Association between increment of serum VEGF level and prognosis after transcatheter arterial chemoembolization in hepatocellular carcinoma patients. Cancer Sci 2008 1.44
25 Reference intervals for circulating angiogenic cytokines. Clin Chem Lab Med 2008 1.40
26 Reversal of drug resistance in breast cancer cells by transglutaminase 2 inhibition and nuclear factor-kappaB inactivation. Cancer Res 2006 1.36
27 Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer. Breast Cancer Res Treat 2010 1.30
28 Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study. J Epidemiol Community Health 2007 1.28
29 Dietary patterns and the metabolic syndrome in obese and non-obese Framingham women. Obes Res 2005 1.23
30 Endogenous sex hormones and cardiovascular disease incidence in men. Ann Intern Med 2006 1.22
31 Site-specific risk factors for colorectal cancer in a Korean population. PLoS One 2011 1.21
32 Electrocardiographic QRS duration and the risk of congestive heart failure: the Framingham Heart Study. Hypertension 2006 1.18
33 Germ line mutations of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients with small bowel cancer: International Society for Gastrointestinal Hereditary Tumours Collaborative Study. Clin Cancer Res 2006 1.18
34 Is the sentinel node biopsy clinically applicable for limited lymphadenectomy and modified gastric resection in gastric cancer? A meta-analysis of feasibility studies. J Surg Oncol 2011 1.18
35 Learning curves for laparoscopic sigmoidectomy used to manage curable sigmoid colon cancer: single-institute, three-surgeon experience. Surg Endosc 2008 1.18
36 Aetiology of cancer in Asia. Asian Pac J Cancer Prev 2008 1.15
37 Single nucleotide polymorphisms of CYP19A1 predict clinical outcomes and adverse events associated with letrozole in patients with metastatic breast cancer. Cancer Chemother Pharmacol 2011 1.13
38 Application of endobronchial ultrasound-guided transbronchial needle aspiration following integrated PET/CT in mediastinal staging of potentially operable non-small cell lung cancer. Chest 2008 1.11
39 Sentinel node mapping and skip metastases in patients with early gastric cancer. Ann Surg Oncol 2009 1.11
40 Stroke risk prediction model: a risk profile from the Korean study. Atherosclerosis 2007 1.10
41 Learning curve for total gastrectomy with D2 lymph node dissection: cumulative sum analysis for qualified surgery. Ann Surg Oncol 2006 1.10
42 Risk stratification of obesity as a coronary risk factor. Am J Cardiol 2002 1.09
43 Validation of the MSKCC and Heng risk criteria models for predicting survival in patients with metastatic renal cell carcinoma treated with sunitinib. Ann Surg Oncol 2013 1.08
44 Effect of Helicobacter pylori infection and its eradication on reflux esophagitis and reflux symptoms. Am J Gastroenterol 2010 1.08
45 Association of the interval between endoscopies with gastric cancer stage at diagnosis in a region of high prevalence. Cancer 2012 1.07
46 Feasibility of laparoscopic sentinel basin dissection for limited resection in early gastric cancer. J Surg Oncol 2008 1.06
47 Gastric cancer and salt preference: a population-based cohort study in Korea. Am J Clin Nutr 2010 1.05
48 Preoperative serum CA-125 levels and risk of suboptimal cytoreduction in ovarian cancer: a meta-analysis. J Surg Oncol 2010 1.04
49 Does neoadjuvant chemotherapy increase optimal cytoreduction rate in advanced ovarian cancer? Meta-analysis of 21 studies. Ann Surg Oncol 2009 1.04
50 A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer. Breast Cancer Res Treat 2007 1.04
51 Predicting tissue HER2 status using serum HER2 levels in patients with metastatic breast cancer. Clin Chem 2006 1.04
52 Carotid intima-media thickness is associated with premature parental coronary heart disease: the Framingham Heart Study. Circulation 2003 1.02
53 Abdominal visceral adipose tissue predicts risk of colorectal adenoma in both sexes. Clin Gastroenterol Hepatol 2010 1.00
54 A phase-II clinical trial of laparoscopy-assisted distal gastrectomy with D2 lymph node dissection for gastric cancer patients. Ann Surg Oncol 2007 0.99
55 Prognostic Impact of [18F] FDG-PET in operable breast cancer treated with neoadjuvant chemotherapy. Ann Surg Oncol 2009 0.99
56 Analysis of chemotherapy-induced amenorrhea rates by three different anthracycline and taxane containing regimens for early breast cancer. Breast Cancer Res Treat 2008 0.98
57 Predictors of timing and patterns of recurrence after curative resection for gastric cancer. Dig Surg 2010 0.98
58 Dietary patterns and the odds of carotid atherosclerosis in women: the Framingham Nutrition Studies. Prev Med 2002 0.98
59 Diagnostic value of (18)F-FDG PET for evaluation of paraaortic nodal metastasis in patients with cervical carcinoma: a metaanalysis. J Nucl Med 2010 0.95
60 Clinical outcome according to the level of preexisting epidermal growth factor receptor T790M mutation in patients with lung cancer harboring sensitive epidermal growth factor receptor mutations. Cancer 2014 0.95
61 Dietary patterns, smoking, and subclinical heart disease in women: opportunities for primary prevention from the Framingham Nutrition Studies. J Am Diet Assoc 2004 0.95
62 Nomogram predicting clinical outcomes in breast cancer patients treated with neoadjuvant chemotherapy. J Cancer Res Clin Oncol 2011 0.95
63 Physical activity and body mass index and their associations with the development of type 2 diabetes in korean men. Am J Epidemiol 2012 0.94
64 The chemokine receptor CCR4 is expressed and associated with a poor prognosis in patients with gastric cancer. Ann Surg 2009 0.94
65 Abdominal shape of gastric cancer patients influences short-term surgical outcomes. Ann Surg Oncol 2007 0.94
66 Association of CYP2A6 polymorphisms with S-1 plus docetaxel therapy outcomes in metastatic gastric cancer. Pharmacogenomics 2009 0.94
67 Factors associated with detection failure and false-negative sentinel node biopsy findings in gastric cancer: results of prospective single center trials. J Surg Oncol 2009 0.93
68 Preoperative plasma fibrinogen level is a useful predictor of adjacent organ involvement in patients with advanced gastric cancer. J Gastric Cancer 2012 0.93
69 Serum and urine levels of interleukin-8 in patients with non-Hodgkin's lymphoma. Cytokine 2008 0.93
70 Health-related quality of life after robot-assisted distal gastrectomy in early gastric cancer. World J Surg 2014 0.92
71 Clinical outcomes of a cohort series of patients with hepatocellular carcinoma in a hepatitis B virus-endemic area. J Gastroenterol Hepatol 2014 0.91
72 Prognostic value of single nodal zone metastasis in non-small-cell lung cancer. Eur J Cardiothorac Surg 2010 0.91
73 Risk assessment tool for distant recurrence after platinum-based concurrent chemoradiation in patients with locally advanced cervical cancer: a Korean gynecologic oncology group study. J Clin Oncol 2012 0.91
74 The role of gefitinib treatment for Korean never-smokers with advanced or metastatic adenocarcinoma of the lung: a prospective study. J Thorac Oncol 2006 0.90
75 Clinical outcomes comparing parenteral and nasogastric tube nutrition after laryngeal and pharyngeal cancer surgery. Dysphagia 2009 0.89
76 Individualized risk prediction model for lung cancer in Korean men. PLoS One 2013 0.88
77 Development and validation of osteoporosis risk-assessment model for Korean postmenopausal women. J Bone Miner Metab 2013 0.87
78 Is adjuvant chemoradiotherapy overtreatment in cervical cancer patients with intermediate risk factors? Int J Radiat Oncol Biol Phys 2010 0.87
79 Risk of lymph node metastasis in differentiated type mucosal early gastric cancer mixed with minor undifferentiated type histology. Ann Surg Oncol 2014 0.87
80 Incremental predictive value of pre-procedural N-terminal pro-B-type natriuretic peptide for short-term recurrence in atrial fibrillation ablation. Clin Res Cardiol 2009 0.86
81 Primary systemic therapy with intermittent weekly paclitaxel plus gemcitabine in patients with stage II and III breast cancer: a phase II trial. Invest New Drugs 2009 0.86
82 Phase II study of weekly paclitaxel and capecitabine in patients with metastatic or recurrent esophageal squamous cell carcinoma. BMC Cancer 2011 0.86
83 Biopsy site for detecting Helicobacter pylori infection in patients with gastric cancer. J Gastroenterol Hepatol 2009 0.85
84 Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancer. Mol Cancer 2011 0.85
85 Preoperative serum angiopoietin-2 levels correlate with lymph node status in patients with early gastric cancer. Ann Surg Oncol 2009 0.84
86 Preoperative serum fibrinogen level predicts postoperative pulmonary complications after lung cancer resection. Ann Thorac Surg 2006 0.84
87 Preoperative [18F]FDG PET/CT maximum standardized uptake value predicts recurrence of uterine cervical cancer. Eur J Nucl Med Mol Imaging 2010 0.84
88 Helicobacter pylori Seropositivity Is Associated with Gastric Cancer Regardless of Tumor Subtype in Korea. Gut Liver 2010 0.83
89 Survival analysis of gastric cancer patients with tumor thrombus in the portal vein. J Surg Oncol 2011 0.83
90 Resected colorectal liver metastases: does the survival differ according to postoperative chemotherapy regimen? J Surg Oncol 2009 0.82
91 Quality of life (QoL) in metastatic breast cancer patients with maintenance paclitaxel plus gemcitabine (PG) chemotherapy: results from phase III, multicenter, randomized trial of maintenance chemotherapy versus observation (KCSG-BR07-02). Breast Cancer Res Treat 2015 0.82
92 Helicobacter pylori infection and histological changes in siblings of young gastric cancer patients. J Gastroenterol Hepatol 2011 0.82
93 Validation of a model to estimate survival in ambulatory patients with hepatocellular carcinoma: a single-centre cohort study. Liver Int 2014 0.82
94 A phase Ib study of preoperative lapatinib, paclitaxel, and gemcitabine combination therapy in women with HER2 positive early breast cancer. Invest New Drugs 2011 0.81
95 Role of high risk-human papilloma virus test in the follow-up of patients who underwent conization of the cervix for cervical intraepithelial neoplasia. J Gynecol Oncol 2009 0.81
96 The lymphangiogenic factor SOX 18: a key indicator to stage gastric tumor progression. Int J Cancer 2011 0.81
97 Efficacy of exemestane after nonsteroidal aromatase inhibitor use in metastatic breast cancer patients. Asian Pac J Cancer Prev 2012 0.80
98 Pretreatment risk factors for multiple gastric cancer and missed lesions. J Surg Oncol 2011 0.79
99 Development and validation of a nutrition screening tool for hospitalized cancer patients. Clin Nutr 2011 0.78
100 Phase II study of irinotecan plus capecitabine in anthracycline- and taxane- pretreated patients with metastatic breast cancer. Invest New Drugs 2012 0.78
101 Risk Factors for TB in Patients With Early Gastric Cancer: Is Gastrectomy a Significant Risk Factor for TB? Chest 2015 0.78
102 Nuclear factor-kappa B inhibition reduces markedly cell proliferation in Epstein-Barr virus-infected stomach cancer, but affects variably in Epstein-Barr virus-negative stomach cancer. Cancer Invest 2010 0.78
103 Carbonic anhydrase XII expression is associated with histologic grade of cervical cancer and superior radiotherapy outcome. Radiat Oncol 2010 0.78
104 Compliance with expert population-based dietary guidelines and lower odds of carotid atherosclerosis in women: the Framingham Nutrition Studies. Am J Clin Nutr 2005 0.78
105 Growth rates of metastatic brain tumors in nonsmall cell lung cancer. Cancer 2008 0.77
106 Advances and Concepts in Cervical Cancer Trials: A Road Map for the Future. Int J Gynecol Cancer 2016 0.76
107 Variations in process and outcome in inpatient palliative care services in Korea. Support Care Cancer 2011 0.75
108 The risk of colorectal cancer is associated with the frequency of meat consumption in a population-based cohort in Korea. Asian Pac J Cancer Prev 2011 0.75
109 Effect of abdominal visceral fat on the development of new erosive oesophagitis: a prospective cohort study. Eur J Gastroenterol Hepatol 2016 0.75
110 Predictive factors of pathologic complete response and clinical tumor progression after preoperative chemotherapy in patients with stage II and III breast cancer. Invest New Drugs 2010 0.75
111 Robot-assisted Versus Laparoscopic Surgery for Rectal Cancer: A Phase II Open Label Prospective Randomized Controlled Trial. Ann Surg 2017 0.75
112 Recovery of Food Intake after Gastrectomy for Gastric Cancer: Based on a Large-Scale Gastric Cancer Cohort. Dig Surg 2017 0.75